Neridronic Acid Completed Phase 2 Trials for Thalassemia Major / Osteoporosis / Thalassemia Intermedia (TI) Treatment

Indications	Status	Purpose	Phase
DBCOND0028907 (Thalassemia Major) DBCOND0015928 (Osteoporosis) DBCOND0051024 (Thalassemia Intermedia (TI))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01140321	Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI	Neridronic Acid (DB11620)